Roche

Roche, headquartered in Basel, Switzerland, is a global leader in biotechnology, focused on improving lives through innovative medicines and diagnostics. It operates through two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals division specializes in medicines for oncology, virology, inflammation, metabolism, and central nervous system disorders, with notable products including Avastin, Herceptin, and MabThera. The Diagnostics division provides a wide range of tests and instruments for clinical chemistry, immunology, virology, and molecular diagnostics, serving hospitals, research labs, and private medical practices. Roche Venture Fund, established in 2002, is the corporate venture capital arm of Roche, investing in early-stage life science companies globally, with a focus on Asia, Europe, and North America. It prefers to invest between CHF1 million to CHF10 million, aiming for a 10-15% ownership stake, and seeks to exit through IPOs or acquisitions.